SKI Market

A+| A| A-|

Indian Indices

Sensex

72,831.48 -751.74
( -1.02%)

Global Indices

Nasdaq

45,202.56 -778.56
(-1.69%)

Dow Jones

6,394.42 -103.74
(-1.60%)

Hang Seng

53,412.46 -191.19
(-0.36%)

Nikkei 225

9,959.27 -12.90
(-0.13%)

Forex

USD-INR

94.09 0.23
(0.24%)

EUR-INR

108.64 -0.12
(-0.11%)

GBP-INR

125.57 -0.09
(-0.07%)

JPY-INR

0.59 0.00
(-0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vivimed Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532660

INE526G01021

0.9167078

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VIVIMEDLAB

45.85

EPS(TTM)

Face Value()

Div & Yield %

Back

itc ltd

Motherson Sumi Wiring India standalone net profit rises 8.72% in the September 2025 quarter

Nov 05,2025

Net profit of Motherson Sumi Wiring India rose 8.72% to Rs 165.34 crore in the quarter ended September 2025 as against Rs 152.08 crore during the previous quarter ended September 2024. Sales rose 18.55% to Rs 2753.87 crore in the quarter ended September 2025 as against Rs 2323.01 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	2753.87	2323.01	19
OPM %	10.16	10.74	-
PBDT	274.12	247.12	11
PBT	221.00	202.72	9
NP	165.34	152.08	9

72,831.48 -751.74 ( -1.02%)

45,202.56 -778.56 (-1.69%)

6,394.42 -103.74 (-1.60%)

53,412.46 -191.19 (-0.36%)

9,959.27 -12.90 (-0.13%)

94.09 0.23 (0.24%)

108.64 -0.12 (-0.11%)

125.57 -0.09 (-0.07%)

0.59 0.00 (-0.07%)